SCHEMBL243697

SCHEMBL243697

CC(=N/c1c(C(C)C)cccc1C(C)C)/C(C)=N\c1c(C(C)C)cccc1C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.50
GABRG2 P18507 2/20 0.50
GABRB3 P28472 2/20 0.50
GABRB2 P47870 2/20 0.50
LMNA P02545 2/20 0.50
FAAH O00519 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
GABRB1 P18505 1/20 0.50
PTGS1 P23219 1/20 0.50
SLC6A2 P23975 1/20 0.50
HTR2C P28335 1/20 0.50
GABRA5 P31644 1/20 0.50
GABRA3 P34903 1/20 0.50
HTR2B P41595 1/20 0.50
GABRA2 P47869 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5354209 1.00 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRB2LMNA
SCHEMBL243698 1.00 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRB2LMNA
SCHEMBL3693753 0.98 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRB2LMNA
Bromide SCHEMBL9938546 0.96 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2LMNA
Bromide SCHEMBL1576200 0.96 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2LMNA
Hydrochloric Acid SCHEMBL6531420 0.96 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2LMNA
Hydrochloric Acid SCHEMBL6357655 0.96 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRB2LMNA
SCHEMBL6355270 0.94 GABRA1 (0.45) GABRA1GABRG2GABRB3GABRB2LMNA
SCHEMBL7053780 0.94 GABRA1 (0.45) GABRA1GABRG2GABRB3GABRB2LMNA
SCHEMBL13725166 0.92 GABRA1 (0.43) GABRA1GABRG2GABRB3GABRB2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363923-B1 RHODIUM AND IRIDIUM COMPLEXES MERCK PATENT GMBH (DE) 2009-04-01 EP claimed
EP-1562964-B1 PALLADIUM AND PLATINUM COMPLEXES MERCK PATENT GMBH (DE) 2006-07-19 EP claimed
US-12631983-B2 Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method FUJIFILM BUSINESS INNOVATION CORP. (JP) 2026-05-19 US disclosed
US-12535752-B2 Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method FUJIFILM BUSINESS INNOVATION CORP. (JP) 2026-01-27 US disclosed
US-12455515-B2 Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method FUJIFILM BUSINESS INNOVATION CORP. (JP) 2025-10-28 US disclosed
EP-4631926-A1 METHOD FOR PRODUCING HOMO-COUPLING REACTION PRODUCT National University Corporation Hokkaido University (JP) 2025-10-15 EP disclosed
EP-4250015-B1 ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD FUJIFILM BUSINESS INNOVATION CORP (JP) 2025-10-08 EP disclosed
US-12421396-B2 Silica particles and method for producing the same FUJIFILM BUSINESS INNOVATION CORP. (JP) 2025-09-23 US disclosed
EP-4250014-B1 ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD FUJIFILM BUSINESS INNOVATION CORP (JP) 2025-09-03 EP disclosed
EP-4343438-B1 ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER, ELECTROSTATIC CHARGE IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD FUJIFILM BUSINESS INNOVATION CORP (JP) 2025-06-04 EP disclosed
EP-4343440-B1 ELECTROSTATIC IMAGE DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD FUJIFILM BUSINESS INNOVATION CORP (JP) 2025-04-23 EP disclosed
US-20050031900-A1 Aromatic monomer-and conjugated polymer-metal complexes SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-02-10 US disclosed
US-20040138455-A1 Rhodium and iridium complexes MERCK PATENT GMBH (DE) 2004-07-15 US disclosed
US-20040127658-A1 Productivity catalysts and microstructure control EASTMAN CHEMICAL COMPANY 2004-07-01 US disclosed
US-20040077809-A1 Productivity catalysts and microstructure control EASTMAN CHEMICAL COMPANY 2004-04-22 US disclosed
EP-1351997-A2 IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL EASTMAN CHEMICAL COMPANY (US) 2003-10-15 EP disclosed
US-6444831-B2 A MONOOLEFINIC COMPOUND IS ADDED TO A FATTY SUBSTANCE THAT COMPRISES TWO CONJUGATED OR UNCONJUGATED ETHYELNE BONDS IN PRESENCE OF A CATALYTIC SYSTEM CONTAINING IRON COMPOUNDS, A REDUCING AGENT, A LIGAND WHICH CONTAINS NITROGEN, ARSANIC ETC INSTITUT FRANCAIS DU PETROLE (FR) 2002-09-03 US disclosed
US-20020065192-A1 Productivity catalysts and microstructure control MACKENZIE PETER BORDEN (US) 2002-05-30 US disclosed
WO-2002036641-A2 IMPROVED PRODUCTIVITY CATALYSTS AND MICROSTRUCTURE CONTROL EASTMAN CHEMICAL COMPANY (US) 2002-05-10 WO disclosed
US-20010005758-A1 Process for the codimerization of polyunsaturated fatty substances and olefins by iron complexes INSTITUT FRANCAIS DE PETROLE (FR) 2001-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138455-A1 Rhodium and iridium complexes RPIA, MPI, INPP5B GABRA1 4094/4885GABRG2 3515/4885GABRB3 4152/4885
US-20040077809-A1 Productivity catalysts and microstructure control MYB, ST3GAL3, FASN GABRA1 4065/4885GABRG2 3300/4885GABRB3 3007/4885
US-12631983-B2 Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method BET1, SMARCC1, SMARCC2 GABRA1 984/4885GABRG2 2037/4885GABRB3 1422/4885
US-12535752-B2 Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method H1-2, H1-0, CECR2 GABRA1 3302/4885GABRG2 4143/4885GABRB3 4170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.